Literature DB >> 4010944

Thymectomy in multiple sclerosis: a 3-year follow-up.

J L Trotter, D B Clifford, E B Montgomery, T B Ferguson.   

Abstract

We studied 34 MS patients who were treated experimentally by thymectomy with or without 1 year of azathioprine therapy. After 3 years, there was no evidence of benefit. Relapsing-remitting patients had done as well or better clinically than controls, and the chronic progressive group did less well statistically than controls.

Entities:  

Mesh:

Year:  1985        PMID: 4010944     DOI: 10.1212/wnl.35.7.1049

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

1.  The role of the thymus in multiple sclerosis.

Authors:  V D'Andrea; G Meco; F Corvese; P F Baselice; V Ambrogi
Journal:  Ital J Neurol Sci       Date:  1989-02

Review 2.  Regulatory T cells in multiple sclerosis and myasthenia gravis.

Authors:  K M Danikowski; S Jayaraman; B S Prabhakar
Journal:  J Neuroinflammation       Date:  2017-06-09       Impact factor: 8.322

Review 3.  The contribution of thymic tolerance to central nervous system autoimmunity.

Authors:  Piero Alberti; Adam E Handel
Journal:  Semin Immunopathol       Date:  2020-10-27       Impact factor: 9.623

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.